Key result
Pharmacist-led care transition intervention fails to improve anticoagulation knowledge or transition quality.
Why the study?
The feasibility, satisfaction, and effectiveness of a care transition intervention with pharmacist home visit and anticoagulation expert consultation for patients with new venous thromboembolism were not established.
Does a pharmacist home visit and anticoagulation expert consultation improve care transition quality, knowledge, and beliefs in patients with a new episode of venous thromboembolism?
Population
Patients with new episode of venous thromboembolism within a not-for-profit health care network
Comparison
Care transition intervention with pharmacist home visit and anticoagulation expert consultation vs control
Design
Randomized controlled trial
Follow-up
30 days
Authors
Loading...
No benefit from pharmacist home visit in new VTE transitions; confirms null effect on knowledge and quality, leaving optimized strategies open for trials.
RCT
Randomized
Does a pharmacist home visit and anticoagulation expert consultation improve care transition quality, knowledge, and beliefs in patients with a new episode of venous thromboembolism?
Absolute Event Rate: 51.5% vs 50.7%
A pharmacist home visit and anticoagulation consultation during care transition for new VTE was feasible but did not significantly improve patient knowledge, beliefs, or care transition quality compared to control.
Kapoor et al. (2019) conducted an RCT in Venous thromboembolism. Pharmacist home visit and anticoagulation expert consultation vs. Control was evaluated on Percentage of knowledge items answered correctly. A care transition intervention comprising a pharmacist home visit and expert consultation did not significantly improve care transition quality, knowledge (51.5% vs 50.7%), or anticoagulant beliefs.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: